DeutschNewstral
Article
Financial Times on 2023-11-09 01:52
Pharmaceuticals sector: Approval for Eli Lilly obesity drug sets up rival to Wegovy
Related news
- Eli Lilly & Co: Eli Lilly to seek obesity drug approval that could disrupt weight loss marketFinancial Times
- IEli Lilly stock price forecast ahead of obesity drug approvalinvezz.com
- FPharmaceuticals sector: Eli Lilly wins US approval for early-stage Alzheimer’s treatmentft.com
Eli Lilly wins FDA nod for obesity drug that rivals Wegovy, Ozempic - Wed, 08 Nov 2023 PSTsyndication.washingtonpost.com
Obesity drug shows promise, Eli Lilly saysArkansas Online- Eli Lilly & Co: Eli Lilly to seek US approval after Alzheimer’s drug trial successFinancial Times
- FEli Lilly & Co: Eli Lilly predicts sales jump from obesity drug demandft.com
Eli Lilly launches website, home delivery option for Wegovy alternative ZepboundNew York Post- IEli Lilly receives FDA approval for its Alzheimer’s drug Kinsulainvezz.com
- Eli Lilly achieves hard-won success with Alzheimer’s and obesity drugsFinancial Times
- Novo Nordisk and Eli Lilly hoover up smaller obesity drug groupsFinancial Times
- KLifestyle Drugs Market Competitive Landscape & Business Opportunities by 2027 | Allergan, BMS, Eli Lilly, Pfizer, Acerus Pharmaceuticalsksusentinel.com
- FPharmaceuticals: Alzheimer’s drug failure deals blow to US drugmaker Eli Lillyft.com
- IEli Lilly to expand in obesity drugs with $1.925 billion acquisition of Versanis Bioinvezz.com
- FEli Lilly says obesity drug’s results compare to weight-loss surgeryft.com
- DEli Lilly says obesity drugs not for 'cosmetic' use amid digital-sales pushdcourier.com
Eli Lilly starts website to connect patients with new obesity treatment, Zepbound, other drugsSeattle Times- KNeuropathy Pain Treatment Market Determined By Key Manufacturing players like Pfizer, Endo, Depomed, Eli Lilly, Arbor Pharmaceuticals, Grünenthal Group.ksusentinel.com
- IEli Lilly secures weight loss drug approval in China: How do rivals stack up?invezz.com